Title : Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes.

Pub. Date : 2018 Apr 20

PMID : 29678165






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 5- year overall survival was affected by anthracycline dose reduction by more than 15% in ER-HER2- group (80% v. 55.6%, p = 0.015), ER + HER2- group (90.7% v. 64.9%, p < 0.01) and ER+/-HER2+ group (100% v. 84.4%, p = 0.019). Anthracyclines erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 5- year overall survival was affected by anthracycline dose reduction by more than 15% in ER-HER2- group (80% v. 55.6%, p = 0.015), ER + HER2- group (90.7% v. 64.9%, p < 0.01) and ER+/-HER2+ group (100% v. 84.4%, p = 0.019). Anthracyclines erb-b2 receptor tyrosine kinase 2 Homo sapiens
3 5- year overall survival was affected by anthracycline dose reduction by more than 15% in ER-HER2- group (80% v. 55.6%, p = 0.015), ER + HER2- group (90.7% v. 64.9%, p < 0.01) and ER+/-HER2+ group (100% v. 84.4%, p = 0.019). Anthracyclines erb-b2 receptor tyrosine kinase 2 Homo sapiens